Which Should You Buy: Valeant Pharmaceuticals Intl Inc. or Home Capital Group Inc.?

Home Capital Group Inc. (TSX:HCG) and Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) have seen their stock prices fall this year. Can either company recover?

| More on:

Stocks that have seen prices decline as a result of scandals and problems present buying opportunities for investors that are not risk averse. The danger in investing in a company that is in turmoil is that the stock could continue to plummet with no end in sight. The easiest example is Sears Canada Inc., which is now in the process of liquidation; months ago, it might have been seen as a bargain opportunity if it could turn things around.

But if is a dangerous word, and just because a stock has declined is not a reason to invest. Instead, it is important, once you find these “bargain” stocks, to look at the company’s financials and assess its long-term prospects. If a company is heavy on debt, sales are declining, and there doesn’t look to be light at the end of the tunnel, it’s best to stay away from the free-falling stock. However, a company ridden by scandals or bad press but has good financials and a promising future might present a good long-term opportunity, as long as you can stomach the fluctuations in the process.

I’ll look at two companies’ stocks that have taken a beating and could present strong long-term upside.

Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) has seen its stock tumble 30% in the past year, and over five years, the stock has declined by over 58%. The company was trading at over $319 a share in September 2015 when news came out about Valeant’s purchase of Addyi, the “female Viagra” pill. The problem with the purchase is, although it was FDA approved, the drug had serious health risks associated with it. Valeant purchased the maker of the high-risk drug for $1 billion, and, as a result, the stock plummeted to $100 a share and soon reached just $34.

Big risks aren’t the only items that have concerned investors. The company is heavily leveraged in debt. At the end of 2015, the company had a debt-to-equity ratio of 5.26 with debt levels reaching over $30 billion. The company was able to bring debt levels down to $29 billion, but a dropping equity resulted in the ratio rising to 9.46 for the end of 2016.

Although the company has expressed a desire to continue paying down its debt, it may be a losing battle, as the company still expects to make large investments into research and development.

Home Capital Group Inc. (TSX:HCG) is a very different case of a company that has been ridden with bad press and scandals in the past several months. The mortgage lender has been involved in fraudulent mortgage applications, and the company’s CEO was fired earlier this year amid accusations of misleading investors.

These types of scandals don’t fade from memory easily, but Berkshire Hathaway Inc. came to the rescue. Berkshire has provided Home Capital with some life support. Home Capital is a bit heavy on debt as well, but with a debt-to-equity ratio of just 1.63 for the latest year, it pales in comparison to the problem Valeant has.

With the problems and individuals associated with fraudulent activities removed from the company, a better balance sheet, and reasonable prospects for a recovery, Home Capital presents a much more attractive opportunity for investors than Valeant.

Fool contributor David Jagielski has no position in any stocks mentioned. Tom Gardner owns shares of Valeant Pharmaceuticals. The Motley Fool owns shares of Valeant Pharmaceuticals.

More on Investing

hand stacks coins
Dividend Stocks

3 Canadian Stocks That Could Be an Ideal Fit for a $7,000 TFSA Investment

A balanced TFSA portfolio starts with the right stocks -- here are three strong contenders.

Read more »

Real estate investment concept
Dividend Stocks

A Reliable Monthly Dividend Stock With a 4.5% Yield Worth Considering

Morguard North American Residential REIT (TSX:MRG.UN) offers a compelling 4.5% yield as it transforms from high-risk payer to blue-chip contender…

Read more »

man in suit looks at a computer with an anxious expression
Dividend Stocks

If I Could Only Buy and Hold a Single Stock, This Would Be It

Thomson Reuters has quietly doubled its financials since 2019. With AI tailwinds, a fortress balance sheet, and 9% legal growth,…

Read more »

panning for gold uncovers nuggets and flakes
Metals and Mining Stocks

1 Gold and Silver Mining Stock to Buy in April

Gold trades above $3,000 and silver above $90. Two mining stocks stand out right now: Agnico Eagle and Endeavour Silver.…

Read more »

stocks climbing green bull market
Investing

The Canadian Stocks I’d Consider If I Had $5,000 to Invest in 2026

In today’s volatile market, investors can balance risks and returns with a balanced portfolio of growth, defensive, and dividend-paying stocks.

Read more »

man crosses arms and hands to make stop sign
Dividend Stocks

The Dividend Stock I Own and Have Zero Intention of Ever Selling

Here's why this dividend stock isn't just one of the best to buy on the TSX, but one you'll never…

Read more »

hot air balloon in a blue sky
Dividend Stocks

3 Canadian Stocks That Could Benefit From a Softer Economy

These three TSX names try to defend a portfolio in a softer economy with essential demand, monthly income, or a…

Read more »

groceries get more expensive as inflation rises
Stocks for Beginners

2 Canadian Stocks That Could Outperform if Inflation Stays Sticky

Sticky inflation could keep pushing investors toward hard assets, and these two miners offer real leverage to gold and silver…

Read more »